Atrial fibrillation in acute coronary syndrome: clinical and anamnestic features and effects on the course

 V.І. TseluykoF.B. Salem, N.A. Lopina, I.V. Kuznetsov

References  

  1. Lang TA, Sesik M. How to describe statistics in medicine. Moskva: Prakticheskaia meditsina, 2011. 480 p.
  2. Lapach SN, Chubenko AV, Babich P.N. Statistical methods in medical-biological research using Excel. Кyiv: Morion, 2001. 408 p.
  3. Parkhomenko AN, Lutai YM., Danshan N. The Ukrainian register of acute myocardial infarction as a fragment of the European: characteristics of patients, organization of medical care and hospital therapy. UMJ. 2011. № 1 (81):21-24.
  4. Rebrova OY. Statistical analysis of medical data. Application of the STATISTICA application package. Moskva: Media Sphere, 2006. 312 p.
  5. Acute coronary syndrome with elevation of segment ST. Order of the Ministry of Health of Ukraine #455 (02.07.2014).
  6. Acute coronary syndrome without elevation of segment ST. Order of the Ministry of Health of Ukraine, 2015.
  7. Chao TF. et al. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. Important because it used a large national health database of people with low CHA2DS2-VASc scores and showed that in similar persons there was an increased risk of MI. Heart Rhythm. 2014;11(11):1941-1947.
  8. Chugh SS. et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014. 129(8):837-847.
  9. Benjamin E, Virani S, Callaway C. et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67-e492.
  10. Ibanez B, James S, Agewall S. et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
  11. January CT. et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-76.
  12. Kea B, Alligood T, Manning V, Raitt M. A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome. Curr Emerg Hosp Med Rep. 2016;4(3):107-118.
  13. Marijon E. et al. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation. 2013;128 (20):2192-2201.
  14. McManus DD, Huang W, Domakonda KV. et al. Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome. Amer J Med. 2012;125 (11):1076-1084.
  15. Mozaffarian D. et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133 (4):e38-e360.
  16. Roffi M, Patrono C, Collet J. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267-315.
  17. Soliman EZ. et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174(1):107-114.
  18. Thygesen K, Alpert JS, Jaffe AS. et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC) / American College of Cardiology (ACC) / American Heart Association (AHA) / World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038.
  19. Rene AG, Généreux P, Ezekowitz M. et al. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2014;113 (2):236-242.
  20. Athar MK, Bagga S, Nair N. et al. Risk of cardiac arrhythmias and conduction abnormalities in patients with acute myocardial infarction receiving packed red blood cell transfusions. J Crit Care. 2011;26 (4):335-341.
  21. Huang SS, Chan WL, Leu HB. et al. Association between CHADS2 score and the preventive effect of statin therapy on new-onset atrial fibrillation in patients with acute myocardial infarction. PLoS One. 2013;8 (8):e74709. 
[PDF] [Contents]